Alexandre Iannello
Cellular Immunologist - Drug Developer - Team Builder
- Role
- Director - Immunology & Inflammation at Genesis Molecular AI
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Alexandre Iannello
Senior drug discovery researcher with 16+ years of post‑PhD experience leading immunology, immuno‑oncology, and autoimmune programs across small molecules, biologics, and cell therapies. Proven track record of building and scaling high‑performing discovery organizations, advancing programs from target identification through IND, and shaping differentiated research portfolios in venture‑backed and platform biotech environments. Key contributor to multiple clinical‑stage assets and platform innovations, with deep expertise in discovery strategy, asset prioritization, and cross‑functional decision‑making. Recognized for combining scientific rigor with strategic leadership to deliver medicines addressing high unmet medical need.
Experience
Director - Immunology & Inflammation
Mar 2026 — Present
Education
UQAM | Université du Québec à Montréal
Master’s Degree, Bioinformatics
2007 — 2009
Pasteur Institute
Master's degree, Microbiology - Virology
2002 — 2004
Université de Montréal
Doctor of Philosophy (Ph.D.), Virology and Immunology
2005 — 2010
Université Grenoble Alpes
Bachelor’s Degree, Cellular Biology
1999 — 2002
Skills
- Immunology
- Virology
- Cell Biology
- Molecular Biology
- Cell Culture
- Infectious Diseases
- Western Blotting
- Cancer Research
- Molecular Cloning
- Fluorescence Microscopy
- Flow Cytometry
- Cell
- In Vivo
- Biochemistry
- Laboratory
- Pcr
- Cancer
- Dna
- Life Sciences
- Cell Based Assays
- Mouse Models
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.